Acadia Healthcare/$ACHC
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Acadia Healthcare
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities. Its facilities and services are classified into the following categories: acute inpatient psychiatric facilities; specialty treatment facilities; CTCs; and residential treatment centers. In which Acute inpatient psychiatric facilities contribute the majority of revenue in the United States. The Company has one reportable segment, behavioral healthcare services. The behavioral healthcare services segment provides inpatient and outpatient behavioral healthcare services.
- Ticker
- $ACHC
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 22,000
- Headquarters
- Franklin, United States
- Website
- www.acadiahealthcare.com
ACHC Metrics
BasicAdvanced
$2.7B
-
-$12.44
0.62
-
Price and volume
Market cap
$2.7B
Beta
0.62
52-week high
$35.83
52-week low
$11.43
Average daily volume
1.5M
Financial strength
Current ratio
1.572
Quick ratio
1.352
Long term debt to equity
1.146
Total debt to equity
1.17
Interest coverage (TTM)
2.24%
Profitability
EBITDA (TTM)
534.847
Gross margin (TTM)
41.06%
Net profit margin (TTM)
-33.44%
Operating margin (TTM)
10.06%
Effective tax rate (TTM)
-2.35%
Revenue per employee (TTM)
$150,000
Management effectiveness
Return on assets (TTM)
3.57%
Return on equity (TTM)
-41.44%
Valuation
Price to revenue (TTM)
0.766
Price to book
1.31
Price to tangible book (TTM)
4.5
Price to free cash flow (TTM)
-19.241
Free cash flow yield (TTM)
-5.20%
Free cash flow per share (TTM)
-1.48
Growth
Revenue change (TTM)
4.27%
Earnings per share change (TTM)
-917.31%
3-year revenue growth (CAGR)
6.63%
10-year revenue growth (CAGR)
3.67%
3-year earnings per share growth (CAGR)
61.57%
10-year earnings per share growth (CAGR)
20.85%
What the Analysts think about ACHC
Analyst ratings (Buy, Hold, Sell) for Acadia Healthcare stock.
Analyst projections of the future price of Acadia Healthcare stock.
Bulls say / Bears say
Acadia raised its 2026 outlook after second-quarter revenue, adjusted EBITDA and adjusted EPS came in at or above guidance. Revenue was flat on the reported basis but grew 2.8% after normalising for prior-period supplemental payments, suggesting underlying demand is improving. (Acadia Healthcare, Acadia Healthcare)
The company is adding capacity quickly, with more than 300 beds added in the first half and 500–600 targeted for 2026. Management says facilities opened from 2023 to 2026 are outperforming start-up targets, giving occupancy gains a path to stronger future earnings. (Acadia Healthcare, Behavioral Health Business)
Cash generation and capital discipline have improved. Acadia generated $124 million of second-quarter free cash flow, repaid $113 million of debt, reduced its full-year capital-spending forecast and expects further positive free cash flow in the second half. (Alphastreet, StockTitan)
The latest quarter showed weak earnings quality: revenue was essentially flat, while net income fell to $10.9 million from $30.1 million and adjusted EBITDA dropped to $149.2 million from $201.8 million. Higher professional-liability reserves and an uninsured legal settlement absorbed much of the operating progress. (Acadia Healthcare, StockTitan)
Federal scrutiny remains an open-ended risk. DOJ and SEC investigations into acute-care admissions, length of stay, billing and CTC practices are unresolved, and Acadia says it cannot yet estimate any potential liability. (StockTitan, Kahn Swick & Foti)
Near-term expansion may not be enough to sustain growth: management expects start-up losses to rise to roughly $12–14 million in the third quarter and has no further de novo or joint-venture project beginning in the fourth quarter or early 2027. That leaves Acadia more dependent on improving existing sites and filling newly added beds. (Exa, GuruFocus)
Data summarised monthly by Lightyear AI. Last updated on 21 Sept 2026.
ACHC Financial Performance
Revenues and expenses
ACHC Earnings Performance
Company profitability
Upcoming events
No upcoming events
ACHC News
AllArticlesVideos
Funds containing ACHC
AllEURUSDGBP
Fund name | Fund size | $ACHC weighting |
|---|---|---|
iShares Ageing Population€AGED | €822M | 0.24% |
iShares S&P SmallCap 600$IDP6 | $3.2B | 0.16% |
iShares S&P Small Cap 600£ISP6 | £2.4B | 0.16% |
SPDR Russell 2000 US Small Cap€R2US | €4.8B | 0.09% |
SPDR Russell 2000 US Small Cap£R2SC | £4.1B | 0.09% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.